Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.94
Delayed Data
As of Feb 26
 +0.13 / +3.41%
Today’s Change
2.81
Today|||52-Week Range
8.47
-17.23%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +255.33% increase from the last price of 3.94.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.15
Sales
--
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.25%
 
 
 
 
 
 
Growthannually 22.22%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account